Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Bakkavor posts strong first-half growth, CFO steps down

(Sharecast News) - Fresh prepared food provider Bakkavor Group announced a strong set of first-half results on Thursday, highlighting revenue growth, improved margins, and debt reduction. The FTSE 250 company reported a 2.8% increase in revenue to £1.12bn, with like-for-like revenue up 3.8%, driven primarily by its UK operations.

Adjusted operating profit rose 26.7% to £55m, resulting in a 4.9% profit margin.

Bakkavor achieved significant operational improvements, reducing operational net debt by £27.8m to £201.8m and lowering its leverage ratio to 1.2x.

The company also raised its interim dividend by 10% to 3.2p per share.

Bakkavor credited strategic progress across its regions for the improved results.

In the UK, volume growth and operational efficiency boosted margins, while in the US, profitability strengthened despite lower revenue.

The company simplified its China business, reducing losses and maintaining cash generation.

Additionally, sustainability efforts in the UK were advancing, though international net carbon emissions increased.

Looking ahead, Bakkavor upgraded its full-year 2024 outlook, expecting adjusted operating profit between £108m and £112m, surpassing market expectations.

The company said it was aiming to rebuild its operating profit margin to 6% in the medium term through ongoing efficiency improvements.

"This has been a strong first half for the group, with momentum from our 2023 restructuring activity continuing to support our performance in 2024," said chief executive officer Mike Edwards.

"We are firmly focused on continuing to rebuild margins and we are pleased to upgrade guidance for 2024 as we look to drive efficiency in every part of our business."

Edwards said the company was "excited" about building a stronger Bakkavor as the trading environment improved, adding that the firm was continuing to leverage the benefit of the actions taken over the last couple of years.

"As such we have a good line of sight to deliver further margin improvement as we move into 2025 and beyond."

In a separate announcement on Thursday, Bakkavor revealed that group chief financial officer Ben Waldron would step down on 31 October, and leave the business by the end of April next year.

Waldron, who had been with the company for almost 14 years, was relocating to Australia to join his partner.

During his tenure, Waldron played a key role in Bakkavor's initial public offering and strategy development, and guided the business through the Covid-19 pandemic as US chief executive.

Lee Miley, currently the UK finance director, would succeed Waldron as CFO and executive director effective 1 November.

Miley, a longtime Bakkavor employee since 1998, had extensive experience in finance and broader responsibilities in mergers and acquisitions, operational excellence, and ESG.

The transition was expected to ensure continuity and momentum within the company.

"Ben has been a most excellent CFO and a pleasure to work with," said chairman Simon Burke.

"We are very sorry to see him go, but we wish him well in Australia.

"Meanwhile we are really pleased to be appointing Lee as our new CFO, confirming our succession planning following a rigorous appointment process which included internal and external candidates."

At 1025 BST, shares in Bakkavor were up 3.71% at 159.72p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

Berenberg lowers target price on Impax Asset Management
(Sharecast News) - Analysts at Berenberg lowered their target price on Impax Asset Management from 620.0p to 560.0p on Tuesday but noted that outflows had started to slow.
GSK's Arexvy provides protection over three RSV seasons, trial shows
(Sharecast News) - GSK has announced positive results from a phase III trial of its Arexvy RSV vaccine, showing that just one dose of the treatment could help protect older adults at risk of RSV disease over three seasons.
S&U revenue up, profitability a challenge in first half
(Sharecast News) - Motor and property finance specialist S&U reported a mixed first-half financial performance on Tuesday, after group revenue increased 9% year-on-year to £60.4m.
Loungers reports slight slowdown in LFL sales growth
(Sharecast News) - Cosy Club owner Loungers reported a slight slowdown in like-for-like sales growth on Tuesday and a jump in revenue.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.